BioMarin Pharmaceuticals Inc

BMRN XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

10B

Short interest (May 15)

5.9%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.41%

↑ 59.3%

Available Shares

↓ 19.3%

Price Chart

Company Overview

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001048477

Asset Type: CS

Market Data

Market Cap: $10,305,926,234

Employees: 3,221

Status: Active

Short Interest

Current Borrow Fee 0.41%

Range: 0.39% - 0.41%

Available Shares 5M

Range: 4M - 4.8M

Recent Changes

Fee Change: ↑ 1.0%

Available Change: ↑ 5.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime